Generalized Epilepsy

Researching an Investigational Treatment Option for Idiopathic Generalized Epilepsy

What to Expect

If you qualify and are enrolled in the study, you will receive the following at no cost:

The investigational medication, or a placebo

All study-related care, testing, and monitoring

Ongoing appointments with the study doctors and qualified medical providers specializing in neurological care

You will continue to see your regular doctors for routine office visits and checkups.

The study will consist of a screening visit, followed by a double-blind phase for up to 24 weeks, then an optional open-label phase for 48 weeks, and a final, follow-up visit once you are done in the study.

The double-blind phase includes up to 7 visits over 24 weeks, followed by an open-label phase that includes 8 visits over 48. The first few visits in each phase are closer together (about once a month for the first 3 months), and then they become less frequent.